Viral Hepatitis
📧 Sign up to get email alerts when something new happens for Viral Hepatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-10-09Clinical Trial Update: The Health Access and Recovery Peer Program [NA]
Clinical trial update for the Health Access and Recovery Peer Program; study completed with posted results.
-
FDA approval · 2019-10-07FDA Approved: LAMIVUDINE — Supplemental Application (Ingenus Pharmaceuticals, LLC)
FDA approved a supplemental application for lamivudine from Ingenus Pharmaceuticals, LLC, confirming authorization for a lamivudine product …
-
FDA approval · 2019-10-03FDA Approved: LAMIVUDINE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for Apotex Corp.'s lamivudine, expanding access to a generic lamivudine product.
-
FDA approval · 2019-09-26FDA Approved: LAMIVUDINE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for lamivudine from Aurobindo Pharma Limited. This action relates to the approval of a supplemen…
-
FDA approval · 2019-09-26FDA Approved: LAMIVUDINE — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for Lamivudine from Strides Pharma Science Limited (ANDA 090457). This action confirms approval of a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-08-29FDA Approved: LAMIVUDINE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approval of a supplemental application for lamivudine by Rising Pharma Holdings, Inc.
-
FDA approval · 2019-05-10FDA Approved: EPIVIR — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for EPIVIR (lamivudine) filed by ViiV Healthcare Company, resulting in label/indication changes thro…
-
CLINICAL_TRIALS trial_result · 2019-03-08Clinical Trial Update: HepNet Pilot Trial: Multicenter Trial for the Treatment of Chronic Hepatitis E With Sofosbuvir (SofE) [Phase 2]
Phase 2 pilot multicenter trial evaluating sofusbuvir-based therapy for chronic hepatitis E has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Protein Biomarker in Hepatocellular Carcinoma
This clinical trial update reports termination of a study evaluating a protein biomarker in hepatocellular carcinoma, sponsored by the Johns…
-
CLINICAL_TRIALS trial_result · 2019-02-04Clinical Trial Update: Twinrix Pregnancy Registry
A pregnancy registry trial for Twinrix by GlaxoSmithKline has completed and posted results.
-
FDA approval · 2018-12-11FDA Approved: VIREAD — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for VIREAD (tenofovir disoproxil fumarate) submitted by Gilead Sciences, Inc.
-
CLINICAL_TRIALS trial_result · 2018-08-08Clinical Trial Update: Feasibility of Interventions on People Who Inject Drugs in Vietnam
A completed clinical trial in Vietnam assessed feasibility of interventions for people who inject drugs, with results posted in 2018.
-
FDA approval · 2018-07-31FDA Approved: TENOFOVIR DISOPROXIL FUMARATE — Original Application (Chartwell RX, LLC.)
FDA approved Tenofovir disoproxil fumarate tablets under an Original Application (ANDA) filed by Chartwell RX, LLC.
-
FDA approval · 2018-07-30FDA Approved: VIREAD — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for VIREAD (tenofovir disoproxil fumarate) submitted by Gilead Sciences, resulting in an updated lab…
-
FDA approval · 2018-04-27FDA Approved: EPIVIR — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for EPIVIR (lamivudine) submitted by ViiV Healthcare Company.
-
FDA approval · 2018-04-27FDA Approved: EPIVIR — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for EPIVIR (lamivudine) submitted by ViiV Healthcare Company.
-
CLINICAL_TRIALS research · 2018-03-07Clinical Trial Update: Incidence Of Hepatitis In Intensive Care Unit
A Sakarya University-led clinical trial investigates the incidence of hepatitis among patients in the intensive care unit; the study status …
-
FDA approval · 2018-01-26FDA Approved: TENOFOVIR DISOPROXIL FUMARATE — Original Application (Strides Pharma Science Limited)
FDA approved the original application for tenofovir disoproxil fumarate as a generic product manufactured by Strides Pharma Science Limited.
-
CLINICAL_TRIALS research · 2017-11-28Clinical Trial Update: Clinical Trial for Evaluation of Treatment With Multiple Infusions of Mononuclear Bone Marrow Cells in Patients With Chronic Liver Diseases [Phase 2]
This is a Phase 2 clinical trial evaluating repeated infusions of bone marrow mononuclear cells in patients with chronic liver diseases, inc…
-
FDA approval · 2017-10-13FDA Approved: PEGASYS — Supplemental Application (pharmaand GmbH)
FDA approved a supplemental application for PEGASYS (peginterferon alfa-2a) submitted by pharmaand GmbH.
-
FDA approval · 2017-09-25FDA Approved: EPIVIR — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for EPIVIR (lamivudine) filed by ViiV Healthcare Company.
-
FDA approval · 2017-09-25FDA Approved: EPIVIR — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for Epivir (lamivudine) submitted by ViiV Healthcare Company.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: MRI to Measure Liver Fat Content [NA]
This clinical trial update notes completion of a study using MRI to measure liver fat content. Conditions include fatty liver disease and he…
-
CLINICAL_TRIALS research · 2017-06-07Clinical Trial Update: Analysis of Trends Over Time of Hepatitis Related Incidence in Panama
An update analyzing how hepatitis-related incidence has trended over time in Panama, sponsored by GlaxoSmithKline.
-
FDA approval · 2017-04-07FDA Approved: VIREAD — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for VIREAD (tenofovir disoproxil fumarate) from Gilead Sciences, Inc.